Ledger.Open graph →
SEC Form D · filed November 13, 2020

Alitair Pharmaceuticals, Inc

Offering
$31.0M
Sold
$35K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MORRISTOWN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

James E. Hoyes · Morristown, NJExec · DirectorRobert E. Casale · Morristown, NJDirectorJoseph Bress · New York, NYDirectorTodd Baldree · Greer, SCExec · DirectorJack Stark · SAN FRANCISCO, CADirectorMatan Friedman · SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗